المؤلفون: Subbiah IM; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Falchook GS; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kaseb AO; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hess KR; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fu S; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subbiah V; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hong DS; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Naing A; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Akmal O; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Janku F; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kurzrock R; Moores Cancer Center, University of California San Diego, San Diego, CA, USA.

المصدر: Oncotarget [Oncotarget] 2015 Sep 29; Vol. 6 (29), pp. 28453-62.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Biomarkers, Tumor/*antagonists & inhibitors , Carcinoma, Hepatocellular/*drug therapy , Liver Neoplasms/*drug therapy, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/metabolism ; Child ; Clinical Trials, Phase I as Topic ; Disease-Free Survival ; Female ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Male ; Middle Aged ; Molecular Targeted Therapy/methods ; Multivariate Analysis ; Mutation ; Outcome Assessment, Health Care/methods ; Outcome Assessment, Health Care/statistics & numerical data ; Prognosis ; Young Adult

المؤلفون: Subbiah V; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States. Electronic address: vsubbiah@mdanderson.org., Berry J; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States., Roxas M; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States., Guha-Thakurta N; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States., Subbiah IM; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States., Ali SM; Foundation Medicine, Boston, MA, United States., McMahon C; Foundation Medicine, Boston, MA, United States., Miller V; Foundation Medicine, Boston, MA, United States., Cascone T; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States., Pai S; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States., Tang Z; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States., Heymach JV; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2015 Jul; Vol. 89 (1), pp. 76-9. Date of Electronic Publication: 2015 Apr 22.

نوع المنشور: Case Reports; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*drug therapy , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy , Oncogene Proteins, Fusion/*genetics, Aged ; Blood-Brain Barrier ; Brain Neoplasms/genetics ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/secondary ; Everolimus/administration & dosage ; Female ; Gene Amplification ; Gene Rearrangement ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Magnetic Resonance Imaging ; Neuroimaging ; Piperidines/administration & dosage ; Proto-Oncogene Proteins c-akt/genetics ; Quinazolines/administration & dosage

المؤلفون: Subbiah IM; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Blackmon SH; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Surgery, The Methodist Hospital and Weill Cornell College of Medicine, Houston, Texas., Correa AM; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kee B; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vaporciyan AA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Swisher SG; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Eng C; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

المصدر: Oncotarget [Oncotarget] 2014 Aug 30; Vol. 5 (16), pp. 6584-93.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Colorectal Neoplasms/*drug therapy , Colorectal Neoplasms/*surgery , Lung Neoplasms/*drug therapy , Lung Neoplasms/*surgery , Metastasectomy/*methods, Camptothecin/administration & dosage ; Camptothecin/analogs & derivatives ; Capecitabine ; Chemotherapy, Adjuvant ; Colorectal Neoplasms/pathology ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/analogs & derivatives ; Humans ; Irinotecan ; Lung Neoplasms/secondary ; Male ; Middle Aged ; Neoadjuvant Therapy ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin ; Preoperative Care/methods ; Prospective Studies ; Survival Rate

المؤلفون: Tsimberidou AM; Phase I Program, Department of Investigational Cancer Therapeutics, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. atsimber@mdanderson.org, Leick MB, Lim J, Fu S, Wheler J, Piha-Paul SA, Hong D, Falchook GS, Naing A, Subbiah IM, Fortier A, Avritscher R, Kurzrock R

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2013 Feb; Vol. 71 (2), pp. 389-97. Date of Electronic Publication: 2012 Nov 11.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Liver Neoplasms/*drug therapy , Liver Neoplasms/*secondary , Organoplatinum Compounds/*administration & dosage , Organoplatinum Compounds/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Female ; Hepatic Artery ; Humans ; Infusions, Intra-Arterial ; Liver Neoplasms/mortality ; Male ; Middle Aged ; Organoplatinum Compounds/adverse effects ; Oxaliplatin

المؤلفون: Subbiah IM; Department of Investigational Cancer Therapeutics. isubbiah@mdanderson.org, Subbiah V, Tsimberidou AM, Naing A, Kaseb AO, Javle M, Fu S, Hong DS, Piha-Paul S, Wheler JJ, Hess KR, Janku F, Falchook GS, Wolff RA, Kurzrock R

المصدر: Oncotarget [Oncotarget] 2013 Jan; Vol. 4 (1), pp. 156-65.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Bile Duct Neoplasms/*drug therapy , Bile Ducts, Intrahepatic/*drug effects , Cholangiocarcinoma/*drug therapy , Gallbladder Neoplasms/*drug therapy, Adult ; Aged ; Analysis of Variance ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Arteriovenous Fistula/chemically induced ; Bile Duct Neoplasms/pathology ; Bile Ducts, Intrahepatic/pathology ; Cholangiocarcinoma/pathology ; Disease-Free Survival ; Female ; Gallbladder Neoplasms/pathology ; Gastrointestinal Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/adverse effects ; Oxaliplatin ; Treatment Outcome

المؤلفون: Tsimberidou AM; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. atsimber@mdanderson.org, Fu S, Subbiah IM, Naing A, Hong DS, Wen S, Fortier AH, Lim J, Kurzrock R

المصدر: Hepato-gastroenterology [Hepatogastroenterology] 2012 Jun; Vol. 59 (116), pp. 960-4.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Thieme Country of Publication: Greece NLM ID: 8007849 Publication Model: Print Cited Medium: Print ISSN: 0172-6390 (Print) Linking ISSN: 01726390 NLM ISO Abbreviation: Hepatogastroenterology Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Peritoneal Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab ; Female ; Humans ; Infusions, Intravenous ; Injections, Intraperitoneal ; Male ; Middle Aged ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/adverse effects ; Oxaliplatin ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Peritoneal Neoplasms/mortality